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http:WHAT THIS PAPER ADDS?
This study has used seven-day continuous ambulatory monitoring in order to objectively quantify the frag-
mented nature of walking bouts in patients with Intermittent Claudication [IC]. Of particular importance is the
description of an index which corresponds to the classic stop/start walking pattern universally described by this
patient group. The index provides a novel, objective, functional outcome speciﬁcally tailored to the unique
impairments experienced by patients with IC. Such an outcome measure could signiﬁcantly enhance the
clinicians’ ability to objectively determine the effectiveness of interventions in both clinical and research
environments.Objective: To develop a method of event-based analysis that quantiﬁes the fragmented nature of walking bouts
in individuals with intermittent claudication [IC] and compare outcomes with age and gender-matched healthy
controls.
Design: Cross-sectional.
Materials: The activPAL physical activity monitor.
Methods: 7-day physical activity patterns were compared between individuals with IC (n ¼ 30) and controls
matched for age and gender (n ¼ 30). The ratio of the number of walking events to upright events was calculated
to provide an event-based claudication index (EBCI) that represented the fragmented nature of walking bouts
commonly reported in those with IC.
Results: Individuals with IC had a greater EBCI than age matched controls indicating a more fragmented walking
pattern (5.8  2.0 vs. 7.7  3.1, p < 0.01). The difference between groups was more pronounced when the EBCI
was calculated from upright events that included >400 steps (23.4  11.3 vs. 35.8  14.2, p < 0.01).
Conclusion: The classic fragmented stop/start walking pattern universally described by individuals with IC can be
quantiﬁed using the EBCI. This method of measurement potentially provides a novel method of assessing the
effectiveness of clinical interventions for this patient group.
Crown Copyright  2012 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. All rights
reserved.
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Many individuals with intermittent claudication (IC) report
that they need to regularly stop whilst walking due to
ischaemic pain. Anecdotally, the more frequently a patient
needs to stop the more severely they are affected by the
condition.1 Assessment of IC using patient interview isresponding author. C.L. Clarke, School of Health and Life Sciences,
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//dx.doi.org/10.1016/j.ejvs.2012.11.027subjective and consequently is an insensitive and poorly
reproducible tool to determine severity of symptoms.2
Objective clinical measurements such as Doppler ultraso-
nography and angiography provide only information on
vessel patency and lesion severity. These imaging tech-
niques provide no information on the functional impact of
the symptoms on the patients’ life.3
Objective measurement of daily physical activity (PA)
patterns may be a particularly useful method for measuring
the functional impact of IC symptoms. Studies using
objective PA measurement devices to measure free-living
daily Energy Expenditure of Physical Activity (EEPA) have
shown that patients with IC have lower PA levels than
healthy controls.4e6
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than 380 kcal/day, 51% lower than age-matched controls
that had an EEPA level of 769 kcal/day.6
Gardner et al. (2007) compared patterns of PA between
individuals with and without IC. They found that individuals
with IC spent less time walking and took fewer steps,
particularly at medium to high cadence levels.7 Gardner
et al. (2008) also reported that patients with earlier onset
ischaemic pain (lower absolute claudication distance (ACD))
may walk more slowly than those with a later onset
ischaemic pain when completing ambulatory activities of
prolonged durations.8 In this particular study,8 prolonged
duration referred to walking continuously between 30 and
60 min. There is evidence that step count moderately
correlates with existing severity measures such as treadmill
testing and post-exercise Ankle Brachial Pressure Index
(ABPi).9 However, cadence and step count does not provide
insight into the pattern by which these steps are accumu-
lated giving no information on the primary symptom of the
need for frequent stops during bouts of walking.
Identiﬁcation and quantiﬁcation of the fragmented
nature of walking bouts in those with IC has not been
investigated. This study aimed to develop and use an event-
based analysis method to compare the fragmented nature
of walking bouts in individuals with and without IC.
MATERIALS AND METHODS
Participants
Thirty patients with varying degrees of IC were recruited
from a vascular out-patient clinic. Thirty healthy participants
on the Glasgow Caledonian University (GCU) PA database
were matched for age and gender.
Ethical approval for this cross-sectional study was ob-
tained from NHS Tayside B Research Ethics Committee and
the Glasgow Caledonian University School of Health Ethics
Committee. All patients were screened for inclusion and
provided written informed consent. Patients were between
50 and 90 years of age and were excluded if their exercise
tolerance was limited by any other factor than ischaemic leg
pain, had active cancer, renal or liver disease, and psychi-
atric disturbance or had had any vascular or other surgical
intervention within the previous six weeks. Patients with
hirsutism were also excluded as the ﬁlm dressing used toFigure 1. a: The activPAL PA monitoattach the monitor to the thigh (Opsite FlexiﬁxTM) did not
maintain its adhesiveness sufﬁciently with this condition.
Procedure
Ankle-brachial pressure index measurement. Ankle-
Brachial Pressure Index (ABPi) was recorded following a 5-
min period of rest in a supine position using a hand-held
5-MHz Doppler probe (Dopplex SD2 Bi-directional pocket
Doppler, Huntleigh Healthcare, Cardiff, UK). Systolic blood
pressure was measured in both dorsalis pedis and posterior
tibial arteries of the lower extremities. Pressures were then
normalised to the higher brachial pressure of either arm to
form the ABPi according to the Transatlantic Intersociety
Consensus for the Management of PAD guidelines (TASC
II).10
Patients had unilateral and/or bilateral disease. The ABPi
for the most symptomatic leg was used for analysis
purposes. Patients with an ABPi >0.9 were not excluded
given that this would have excluded those participants with
IC and calciﬁcation of the arteries. When an ABPi
measurement was recorded and diagnosis of arterial
disease was still in question; an exercise test (using a calf
ergonometer) was performed in conjunction with Duplex
ultrasound and/or Magnetic Resonance Angiogram (MRA)
to conﬁrm diagnosis.
ActivPAL physical activity monitor. Daily free-living PA
was measured using the activPAL uni-axial PA monitor
(PAL Technologies, Glasgow, UK); a small unobtrusive
accelerometer-based device with dimensions of
53  35  7 mm and weighing only 15 g. The monitor was
wrapped in a waterproof sleeve and attached to the ante-
rior part of patients’ right mid-thigh with Opsite FlexiﬁxTM
transparent dressing and worn continuously for 7-days
(Fig. 1). Participants were able to shower whilst wearing the
device and had the option of removing it if required.
The activPAL monitor allows for differentiation of
sedentary [sitting or lying], standing and ambulatory activity
using proprietary algorithms (Intelligent Activity Classi-
ﬁcation, PAL Technologies). It has been validated for the
amount of time spent sedentary, upright, standing and
stepping and has also shown to be highly accurate for step
number and cadence.11e13 The activPAL has been used
with a range of clinical populations including back pain,14r. b: Monitor attachment to thigh.
Figure 2. Total steps over 7-day period in individuals with IC and
controls.
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ulceration.19
PA outcomes. The output from the monitor is a classiﬁca-
tion of events (sedentary, standing, individual steps) and
from this primary classiﬁcation continuous walking events
can be deﬁned by combining individual step events. Upright
events can be deﬁned by combining the standing and
walking events. Analysis was then performed on these
events. The hypothesis was that individuals with IC would
have on average more walking events per upright event as
they would need to stop and start more frequently due to
ischaemic pain. The ratio of walking events to upright
events was calculated to provide an event-based claudica-
tion index (EBCI). It was proposed that this quantiﬁed the
fragmented nature of walking bouts.
The outcomes were total number of upright events,
walking events, steps per day and the EBCI. In addition
a ﬁlter was applied to the upright events to remove upright
events which contained periods of walking events below
certain thresholds deﬁned for the duration of walking and
also for number of steps with the upright event. It was
hypothesised that ischaemic pain would generally arise
following longer duration walking bouts and so therefore
EBCI values were compared for upright events above 1, 2, 5
and 10 min duration. In addition, a deﬁned threshold of
number of steps was applied. These thresholds were 50,
100, 200 and 400 steps per upright event. A comparison
was made for all outcomes between the two groups.RESULTS
Sample
There were thirty participants in each group (18 males and
12 females) and the mean age was 67.2  9.7 years in those
with IC and 66.8  10.5 years in the control group. The BMI
for those with IC was 26.2  4.0 and for controls was
26.0  4.4. All individuals with IC reported unilateral or
bilateral symptoms for a mean 4.1  4.9 years and mean
ABPi was 0.83  0.28. In the patient group 24 (80%) were
retired, 1 worked part-time (3.3%) and 5 worked full-time
(16.7%). In the control group 19 were retired (63.3%), 2
were employed part-time (6.7%) and 9 worked full time
(30%).
Two control participants failed to keep the device in
place for a full 7 days (with 1 participant removing it after
6 days and the other after 5 days). The reasons for
removal are unknown. The monitor could easily be
removed and reattached by the participant. All those with
IC kept the device in situ continuously and did not report
any problems with wearing the monitor whilst taking
a shower or sleeping.Figure 3. Total number of walking events per upright event (EBCI)
over 7-day period in individuals with IC and controls.Physical activity outcomes
Controls had on average a higher total number of steps than
those with IC per day (8664  3110 vs. 6524  2710
respectively e see Fig. 2).Individuals with IC had a higher number of walking
events per upright event (EBCI) than controls (8  3 vs.
6  2 respectively e see Fig. 3).
The relationship between the EBCI and total number of
steps taken per day was assessed (Fig. 4). Individuals with
IC, in general, took more walking events per upright event
to achieve the same step count as controls.Relationship between duration of walking events and EBCI
The number of upright events, walking events, steps and
the EBCI were compared for different walking duration
thresholds (see Table 1). When the duration and step
threshold were set to zero, all walking events and all upright
events were included in analysis. There was no signiﬁcant
difference between the number of upright events between
the two groups (p > 0.05). Individuals with IC had signiﬁ-
cantly more walking events, less steps and a higher EBCI
(indicating more walking event per upright event) than
controls at all duration thresholds (p < 0.02). The ratio for
each outcome, between the IC and control group, was
unaffected by the magnitude of the duration threshold.Relationship between step threshold and EBCI
The number of upright events, walking events, steps and
the EBCI were compared for different step thresholds (see
Table 2). Again there was no signiﬁcant difference between
Figure 4. Relationship between event-based claudication index and
total steps per day.
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(p > 0.05). Individuals with IC had signiﬁcantly more
walking events at baseline than controls (p < 0.01) and in
walking events consisting of 50 steps or less (p < 0.05)
however; this trend was not signiﬁcant in walking events
consisting of 100 steps or more (p > 0.05). The difference in
the ratio of the EBCI, between the IC and control group, was
more pronounced for upright events containing a larger
number of steps.DISCUSSION
This study found that continuous 7-day PA monitoring is
able to identify and quantify differences in walking behav-
iour between patients with IC and healthy age-matched
controls. Of particular importance is the quantiﬁcation of
the broken nature of walking activity in these groups using
an event-based claudication index (EBCI) which expresses
the average number of walking events per upright event.
This index corresponds to the classic stop start walking
pattern universally described by individuals with IC and mayTable 1. Daily number of upright events, walking events, steps and EB
Duration threshold (mins) 0 1
Upright events CO 51.4  14.6 36.9  9.0
IC 53.0  17.0 38.4  12.0
IC/CO 1.03 1.05
p value 0.7277 0.5467
Walking events CO 318.3  75.9 299.3  75.0
IC 415.0  160 393.1  158.0
IC/CO 1.32 1.30
p value *0.0047 *0.0053
Steps CO 8664.0  3110.0 8437.0  3070.3
IC 6524.0  2710.0 6290.3  2703.4
IC/CO 0.75 0.75
p value *0.0062 *0.0057
EBCI CO 5.80  2.0 7.98  2.2
IC 7.67  3.1 10.38  4.2
IC/CO 1.32 1.30
p value *0.0071 *0.0085
CO ¼ control group participants. IC ¼ participants with IC.be a particularly useful way of objectively quantifying the
severity of functional impairment experienced by this
patient group.
It was hypothesised that short bursts of upright activity
may be due to the completion of everyday household
activities of daily living (i.e. washing up) rather than activ-
ities which may contain more purposeful walking (i.e.
walking to the shops) where ischaemic pain is more likely to
arise. It has been reported in the relevant literature that
ambulation consisting of less than ﬁve minutes duration is
more characteristic of activities requiring short burst-
activity rather than of more sustained, endurance-related
activities.7 In order to investigate this, the EBCI was
compared for upright events using different thresholds for
duration of walking and number of steps. When thresholds
for duration of walking and number of steps were set to
zero, those individuals with IC took on average 2140 less
steps per day than controls. This ﬁnding is supported by
similar studies that have found that those with IC have
lower daily physical activity levels due to both walking for
less time and taking fewer steps per day than those without
IC.4,7 However, the novel ﬁnding in this study is that those
with IC had on average 97 more walking events per upright
event than those without IC. We propose that this ﬁnding
reﬂects the fragmented walking pattern described by this
patient group.
The EBCI ratio was unaffected by the magnitude of the
duration of upright time (Refer to Table 1: IC/CO range
between 1.28 and 1.32). However, it became more
pronounced when the step threshold increased, i.e. for
upright events containing a larger number of steps (Refer to
Table 2: IC/CO range 1.32e1.53). This indicated that walking
behaviour was even more fragmented during more
purposeful walking events periods, which might be ex-
pected given the possibility of ischaemic pain during pro-
longed activity. Fig. 4 illustrates this ﬁnding in that thoseCI values for different duration thresholds.
2 5 10
29.1  6.7 17.1  4.3 9.1  2.7
30.0  10.0 17.3  6.1 10.0  0.4
1.02 1.00 1.06
0.7956 0.9530 0.4991
283.0  74.0 236.0  70.3 178.2  64.4
370.0  157.4 312.0  151.1 248.4  140.0
1.32 1.32 1.28
*0.0088 *0.0165 *0.0165
8160.1  3007.1 7268.0  2860.1 5994.1  2607.3
5994.0  2703.0 5227.0  2661.4 4337.0  2561.0
0.73 0.72 0.72
*0.0048 *0.0059 *0.0159
9.49  2.7 13.53  4.2 19.12  6.9
12.54  4.8 17.92  6.6 24.56  8.4
1.32 1.32 1.28
*0.0041 *0.0032 *0.0083
Table 2. Daily number of upright events, walking events, steps and EBCI values for different step thresholds.
Step threshold 0 50 100 200 400
Upright events CO 51.4  14.6 25.0  7.1 16.0  5.4 9.0  3.4 4.3  2.0
IC 53.0  17.0 23.0  8.1 13.1  6.0 6.9  3.9 3.3  2.0
IC/CO 1.03 0.93 0.84 0.81 0.77
p value 0.7277 0.3684 0.0785 0.0897 0.0652
Walking events CO 318.3  75.9 263.7  74.0 219.0  74.1 158.0  68.4 100.4  55.1
IC 415.0  160 339.4  158.0 277.0  154.3 204.1  140.1 131.0  109.1
IC/CO 1.32 1.36 1.49 1.52 1.53
p value *0.0047 *0.0221 0.0720 0.1116 0.1847
Steps CO 8664.0  3110.0 8123.0 3071.0 7480.1  3026.1 6470.0  2849.0 5291.0  2650.0
IC 6524.0  2710.0 5877.3 2746.0 5179.0 2738.0 4301.0  2628.0 3290.0  2327.0
IC/CO 0.75 0.72 0.69 0.66 0.62
p value *0.0062 *0.0041 *0.0031 *0.0033 *0.0029
EBCI CO 5.80  2.0 10.72  3.5 13.76  4.9 18.59  7.5 23.39  11.3
IC 7.67  3.1 14.59  5.3 20.44  7.2 28.24  9.3 35.79  14.2
IC/CO 1.32 1.36 1.49 1.52 1.53
p value *0.0071 *0.0016 *0.0001 *0.0000 *0.0004
CO ¼ control group participants. IC ¼ participants with IC.
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event in order to perform a similar amount of steps as those
without IC.
A limitation of this study is the lack of a robust control
group. This limitation is a consequence of cross sectional
studies in general. Although groups were matched for age
and gender; comparisons were made from patients from
the Glasgow Caledonian University PA database rather than
a control sample recruited for the purposes of this study.
However use of such PA databases to provide matched
controls for clinical groups is often used within the
literature.20
Participants with IC were at various stages of clinical
management and thus had varying degrees of symptom
severity. This could have inﬂuenced ﬁndings as some
participants with IC had similar patterns of physical activity
as controls; whereas others had very obviously different
activity levels (Refer to Fig. 4). Peripheral arterial disease
was not speciﬁcally excluded in the control group via the
measurement of the ABPi and we recognise PAD may have
been an inﬂuencing factor. However, all participants were
classiﬁed as healthy older adults with no reported leg pains
on walking.
A control group with other chronic disorders was
considered; however these groups may have presented
with other problems which would have inﬂuenced walking
behaviour. In addition, whilst measures were taken in this
study to exclude any participant if their exercise tolerance
was limited by any other factor than ischaemic leg pain;
issues such as environmental factors may have inﬂuenced
results relating to a more fragmented walking pattern found
in the patient group.
In conclusion, seven-day continuous ambulatory moni-
toring is able to objectively quantify the fragmented nature
of walking bouts in patients with IC. Of particularimportance is the identiﬁcation of an EBCI index which
corresponds to the classic fragmented stop/start walking
pattern universally described by patients with IC. This
method of measurement and quantiﬁcation potentially
provides a novel simple method of assessing the effec-
tiveness of clinical interventions for this patient group.
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